Overcome the translational challenges limiting the development of the next generation of CKD therapeutics. For the 3rd year, the Chronic Kidney Disease Drug Development Summit...

The Biomarkers for Alzheimer's Disease Summit is the industry's only digital forum dedicated to solving the challenges of developing clinically validated biomarkers for the...

The Biomarkers for Alzheimer's Disease Summit is the industry's only digital forum dedicated to solving the challenges of developing clinically validated biomarkers for the...

The Biomarkers for Alzheimer's Disease Summit is the industry's only digital forum dedicated to solving the challenges of developing clinically validated biomarkers for the...

Keeping updated on the latest trends in Biomedical Engineering and related areas. United Scientific Group-A non-profit scientific organization hosting 2nd Biomedical Engineering...

After more than a decade of effort to develop RNAi-based therapeutics, everything changed when two RNAi-based drugs received recent FDA approval, opening the door to...

Immunogenicity compromises both the efficacy and safety of gene therapies and thus represents one of the most prominent challenges that must be overcome in the field. Uniting...

WHAT IS SMALL BUSINESS EXPO? Small Business Expo is America's BIGGEST and most anticipated business-to-business networking and educational event, trade show and conference for...

The inaugural Commercializing Flow Chemistry Summit is your catalyst to bridge the gap between using flow for a single step in RandD to supporting fully integrated GMP drug...

As the scientific community search for alternatives to broad spectrum antibiotics, phage therapy has re-emerged as a viable solution to tackle the global health challenge of...

Via the latest data driven case studies from academic and industry pioneers, the 2nd RAS Targeted Drug Development Summit will shine a spotlight on optimizing the selectivity...

In a year that saw a significant rise in the clinical pipeline of cannabis-derived therapeutics and the worldwide sales of Epidiolex soar, the 3rd International Cannabinoid...

The World's Largest MBA Tour is coming to Boston on Tuesday, September 22nd. Register now and join us for FREE to meet with several top business schools, all under one roof! At...

The World's Largest MBA Tour is coming to Boston on Tuesday, September 22nd. Register now and join us for FREE to meet with several top business schools, all under one roof! At...

The World's Largest MBA Tour is coming to Boston on Tuesday, September 22nd. Register now and join us for FREE to meet with several top business schools, all under one roof! At...

Built with insights from the likes of AbbVie, Sanofi, Amgen and Takeda; CDD for Biologics has been specifically designed to help biopharma companies define strategies to...

The life sciences are seeing developments in new technologies and undergoing a period of dramatic change and innovation, all of which are challenging traditional IP strategies...

The hotly anticipated B-Cell Directed Therapies for Autoimmune Diseases Virtual Summit is here to equip you with the expert insight and novel strategies to ensure the...

The 2nd Allogeneic Cell Therapies Summit is the only meeting completely focussed on advancing the development of off-the-shelf therapies by advancing cryopreservation...

The global pre-filled syringes market was valued at $4.9 billion in 2018 and with the rapid growth of the industry, is expected to exceed $9.7 billion by 2025. With that in...

With the explosive excitement and clinical proof of concept utilizing CD47 approaches, 2020 is the year for macrophage development, as we witness greater interest and...

SPONSORED BY: Associates of Cape Cod, bioMérieux, Bioscience International, C.T.L. MAT, LONZA CHAIRED BY: Lynne Ensor,VP Technical, Parexel The pharmaceutical microbiology...

- Implement robust, patient-centric supply chains for clinical to commercial readiness - Optimize patient care with best practice guidelines and integrated platforms - Maintain...

The 3rd Lifecycle Management for Combination Products Summit is the only peer-led community that is bringing over 100+ senior leaders from drug-device teams including...

Finally Drugging The "Undruggable" Proteome With about 85% of the proteome currently undrugged, accessing these targets that are, at present, extremely difficult to drug, has...

The NASH Summit offers an unrivalled, market leading opportunity to learn cutting-edge insights into the successes, setbacks and innovations in NASH drug development from the...